AstraZeneca and Absci partnership paves the way for AI-generated cancer antibodies, potentially eliminating the need for chemotherapy

AstraZeneca and Absci have signed a deal worth $247 million to collaborate on developing cancer antibodies using generative AI, reports Reuters. AstraZeneca aims to replace chemotherapy and sees this partnership as a significant step towards achieving that goal. They plan to use Absci’s AI technology for large-scale protein analysis to search for a workable cancer […]

Continue Reading

Integration of Google’s AI Technology Enhances Voice Analytics in the Finance Industry for Symphony

Symphony is collaborating with Google to improve voice analytics capabilities for banks and investment firms. This partnership is a response to increased regulatory scrutiny on communications compliance within the financial industry. Heightened pressure from the US Securities and Exchange Commission (SEC) has led to over $2 billion in fines due to failures in tracking or […]

Continue Reading